Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis

被引：4
|
作者：
John, Nevin [1 ]
Carroll, Antonia [2 ]
Brownlee, Wallace J. [2 ,3 ]
Chataway, Jeremy [1 ,2 ]
机构：
[1] UCL, Inst Neurol, Neuroinflammat, London WC1N 3BG, England
[2] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England
[3] Queen Sq Multiple Sclerosis Ctr, Dept Neuroinflammat, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷 / 12期
关键词：
FINGOLIMOD;
D O I：
10.1136/jnnp-2019-320687
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1376 / +
页数：3
相关论文
共 50 条
  • [41] The Efficacy of Natalizumab in Patients with Relapsing Multiple Sclerosis in a Clinical Practice Setting
    Foley, John F.
    NEUROLOGY, 2009, 72 (11) : A239 - A239
  • [42] Characteristics of PML cases in multiple sclerosis patients switching to fingolimod from natalizumab
    Putzki, N.
    Clifford, D. B.
    Bischof, D.
    Moore, A.
    Weinshenker, B. G.
    Freedman, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 43 - 43
  • [43] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
  • [44] Sustained Improvement in Physical Disability with Natalizumab in Patients with Relapsing Multiple Sclerosis
    Munschauer, Fredrick
    Giovannoni, Gauin
    Lublin, Fred
    O'Connor, Paul
    Phillips, J. T.
    Polman, Chris
    Pace, Amy
    Panzara, Michael
    Pace, Amy
    Kim, Richard
    NEUROLOGY, 2009, 72 (11) : A314 - A314
  • [45] Switching from natalizumab to alemtuzumab: a case series
    John, N. A.
    Carroll, A.
    Shields, A.
    Brownlee, W.
    Chataway, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 646 - 647
  • [46] Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis
    O'Leary, Shirley
    Brugger, Helen T.
    Wallentine, Dale
    Sershon, Lisa
    Goff, Erica
    Saldana-King, Toni
    Beavin, Jill
    Avila, Robin L.
    Rutledge, Danette
    Moore, Marie
    JOURNAL OF INFUSION NURSING, 2023, 46 (06) : 347 - 359
  • [47] Cost effectiveness and budget impact of natalizumab in patients with relapsing multiple sclerosis
    Chiao, Evelyn
    Meyer, Kellie
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (06) : 1445 - 1454
  • [48] Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis
    Cobo-Calvo, Alvaro
    Bau, Laura
    Matas, Elisabet
    Romero-Pinel, Lucia
    Mane Martinez, M. Alba
    Majos, Carles
    Martinez Yelamos, Sergio
    EUROPEAN NEUROLOGY, 2015, 73 (3-4) : 220 - 229
  • [49] The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis
    Dalton, C
    Barker, G
    MacManus, D
    Miszkiel, K
    Bates, D
    Blumhardt, L
    Hawkins, C
    Palace, J
    Sharief, M
    Swingler, R
    Young, C
    Miller, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03): : 399 - 399
  • [50] Rebound Disease Activity Reduction in Relapsing Multiple Sclerosis Patients Transitioned From Natalizumab to Teriflunomide
    Cohan, Stanley
    Edwards, Keith R.
    Chen, Chiayi
    Gervasi, Tiffany
    O'Connor, Judy
    Smoot, Kyle
    Kresa-Reahl, Kiren
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 70 - 70
12345